EGF and cancer: In bresat cancer, STAT3 activation by EGF treatment induced higher Snail expression and the high expression level of snail was reversed by N-myc downstream-regulated gene 2 (NDRG2) through inhibits STAT3 binding to the Snail promoter and subsequently inhibit the EMT process and cancer progression58.